Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02214069 · ClinicalTrials.gov registry record
Using Smart Phone Technology in Detecting the Presence of Atrial Fibrillation
A clinical trial, sponsored by The Cleveland Clinic.
- Completed
- Registry status
- 60
- Enrollment target
NCT02214069 is a clinical trial that has completed, run by The Cleveland Clinic. The registered enrollment target is 60 participants.
The verdict
NCT02214069 has completed, sponsored by The Cleveland Clinic.
- COMPLETED
- Registry status
- 60 participants
- Enrollment target
Study Summary
The purpose of this study is to examine whether patients can use the AliveCor case to record their heart rhythm and to assess the accuracy of the software in detecting AF vs sinus rhythm
Interventions
- DEVICE Record and transmit heart rhythm
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2014-08 |
| Est. Completion | 2017-07 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02214069
The ClinicalTrials.gov registry entry for NCT02214069 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is The Cleveland Clinic, which has 688 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Record and transmit heart rhythm is the first listed.
NCT02214069 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02214069 about?
NCT02214069 is a clinical study titled "Using Smart Phone Technology in Detecting the Presence of Atrial Fibrillation". The purpose of this study is to examine whether patients can use the AliveCor case to record their heart rhythm and to assess the accuracy of the software in detecting AF vs sinus rhythm
What is the current status of trial NCT02214069?
This trial is currently completed. The enrollment target is 60 participants. The study started on 2014-08. Estimated completion is 2017-07.
What interventions are being tested in trial NCT02214069?
The interventions under investigation include: Record and transmit heart rhythm (DEVICE).
Who is sponsoring clinical trial NCT02214069?
This trial is sponsored by The Cleveland Clinic, which has 688 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.